Trinity Biotech (TRIB) Return on Assets (2009 - 2025)

Trinity Biotech's Return on Assets history runs 17 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.0% for Q4 2025 at Trinity Biotech, up from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2021 to a low of 0.01% in Q3 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
• On a YoY basis, Return on Assets climbed as much as 0 bps in 2021 and fell as far as 0 bps in 2021.
• Trinity Biotech's Return on Assets stood at 0.0% in 2021, then plunged by 1735 bps to 0.0% in 2022, then plunged by 30 bps to 0.01% in 2023, then soared by 49 bps to 0.0% in 2024, then surged by 34 bps to 0.0% in 2025.
• According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison